MediciNova, Inc. Forecast, price target & analysts
$1.33
3.62%
yesterday
Nasdaq,
Jun 13, 10:00 pm CET
MediciNova, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
MediciNova, Inc. Classifications & Recommendation:
Buy
100%
MediciNova, Inc. Price Target
| Target Price | $9.00 |
| Price | $1.33 |
| Potential |
576.69%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a MediciNova, Inc. price target 2026.
The average MediciNova, Inc. target price is $9.00.
This is
576.69%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend MediciNova, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediciNova, Inc. stock has an average upside potential 2026 of
576.69%
register free of charge
|
Current MediciNova, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Dec 06 2024 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Dec 06 2024 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Dec 02 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
